Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RCUS |
---|---|---|
09:32 ET | 4694 | 17.21 |
09:35 ET | 200 | 17.155 |
09:44 ET | 100 | 17.2 |
09:46 ET | 650 | 17.11 |
09:48 ET | 600 | 17.18 |
09:51 ET | 300 | 17.335 |
09:55 ET | 800 | 17.345 |
09:57 ET | 500 | 17.345 |
10:00 ET | 700 | 17.34 |
10:02 ET | 100 | 17.34 |
10:04 ET | 1925 | 17.485 |
10:06 ET | 1680 | 17.43 |
10:08 ET | 300 | 17.425 |
10:13 ET | 633 | 17.448 |
10:15 ET | 600 | 17.45 |
10:18 ET | 200 | 17.46 |
10:20 ET | 1742 | 17.5 |
10:22 ET | 1170 | 17.45 |
10:24 ET | 1126 | 17.44 |
10:26 ET | 600 | 17.505 |
10:27 ET | 201 | 17.455 |
10:29 ET | 200 | 17.445 |
10:31 ET | 1098 | 17.45 |
10:33 ET | 1101 | 17.36 |
10:36 ET | 1625 | 17.455 |
10:38 ET | 100 | 17.455 |
10:42 ET | 200 | 17.46 |
10:44 ET | 1200 | 17.45 |
10:45 ET | 500 | 17.45 |
10:49 ET | 821 | 17.45 |
10:51 ET | 4157 | 17.38 |
10:54 ET | 2786 | 17.39 |
10:56 ET | 500 | 17.44 |
10:58 ET | 1048 | 17.48 |
11:00 ET | 2168 | 17.5 |
11:02 ET | 732 | 17.55 |
11:03 ET | 934 | 17.48 |
11:05 ET | 300 | 17.55 |
11:07 ET | 465 | 17.55 |
11:09 ET | 200 | 17.52 |
11:12 ET | 331 | 17.57 |
11:14 ET | 100 | 17.53 |
11:16 ET | 100 | 17.53 |
11:18 ET | 200 | 17.54 |
11:20 ET | 700 | 17.53 |
11:21 ET | 1000 | 17.6 |
11:23 ET | 400 | 17.515 |
11:25 ET | 2304 | 17.54 |
11:27 ET | 314 | 17.485 |
11:30 ET | 602 | 17.52 |
11:34 ET | 200 | 17.52 |
11:36 ET | 124 | 17.55 |
11:38 ET | 1036 | 17.55 |
11:39 ET | 302 | 17.56 |
11:41 ET | 213 | 17.57 |
11:43 ET | 1063 | 17.63 |
11:48 ET | 163 | 17.62 |
11:50 ET | 1904 | 17.675 |
11:52 ET | 100 | 17.67 |
11:56 ET | 100 | 17.65 |
11:57 ET | 528 | 17.67 |
11:59 ET | 300 | 17.7 |
12:01 ET | 325 | 17.72 |
12:03 ET | 300 | 17.68 |
12:06 ET | 100 | 17.65 |
12:08 ET | 200 | 17.655 |
12:10 ET | 902 | 17.66 |
12:12 ET | 900 | 17.68 |
12:14 ET | 400 | 17.735 |
12:15 ET | 200 | 17.74 |
12:17 ET | 100 | 17.69 |
12:19 ET | 208 | 17.67 |
12:26 ET | 1142 | 17.655 |
12:28 ET | 800 | 17.61 |
12:30 ET | 300 | 17.62 |
12:33 ET | 200 | 17.625 |
12:37 ET | 1014 | 17.62 |
12:42 ET | 300 | 17.64 |
12:44 ET | 975 | 17.63 |
12:46 ET | 100 | 17.635 |
12:48 ET | 1121 | 17.7 |
12:50 ET | 300 | 17.7 |
12:53 ET | 400 | 17.73 |
12:55 ET | 100 | 17.725 |
12:57 ET | 642 | 17.7 |
01:00 ET | 986 | 17.71 |
01:02 ET | 9475 | 17.62 |
01:04 ET | 2000 | 17.61 |
01:06 ET | 205 | 17.705 |
01:08 ET | 100 | 17.705 |
01:09 ET | 1909 | 17.705 |
01:11 ET | 474 | 17.74 |
01:13 ET | 148 | 17.72 |
01:18 ET | 100 | 17.665 |
01:20 ET | 1400 | 17.685 |
01:22 ET | 100 | 17.65 |
01:24 ET | 108 | 17.679 |
01:26 ET | 300 | 17.67 |
01:27 ET | 200 | 17.68 |
01:31 ET | 917 | 17.73 |
01:40 ET | 200 | 17.63 |
01:42 ET | 400 | 17.67 |
01:44 ET | 100 | 17.67 |
01:45 ET | 444 | 17.605 |
01:47 ET | 300 | 17.62 |
01:49 ET | 400 | 17.605 |
01:51 ET | 1374 | 17.64 |
01:54 ET | 200 | 17.64 |
01:56 ET | 1000 | 17.645 |
01:58 ET | 2384 | 17.655 |
02:00 ET | 200 | 17.65 |
02:02 ET | 400 | 17.65 |
02:03 ET | 200 | 17.655 |
02:07 ET | 1526 | 17.69 |
02:09 ET | 705 | 17.68 |
02:12 ET | 14100 | 17.675 |
02:14 ET | 2405 | 17.725 |
02:16 ET | 899 | 17.72 |
02:18 ET | 100 | 17.71 |
02:20 ET | 500 | 17.7 |
02:21 ET | 437 | 17.74 |
02:23 ET | 651 | 17.73 |
02:25 ET | 300 | 17.73 |
02:27 ET | 11843 | 17.76 |
02:32 ET | 260 | 17.79 |
02:34 ET | 200 | 17.7975 |
02:36 ET | 505 | 17.79 |
02:38 ET | 731 | 17.81 |
02:43 ET | 200 | 17.81 |
02:45 ET | 100 | 17.8 |
02:48 ET | 200 | 17.81 |
02:50 ET | 1094 | 17.84 |
02:52 ET | 100 | 17.855 |
02:54 ET | 1808 | 17.83 |
02:56 ET | 100 | 17.79 |
02:57 ET | 268 | 17.81 |
03:01 ET | 201 | 17.79 |
03:03 ET | 451 | 17.82 |
03:06 ET | 658 | 17.8 |
03:08 ET | 243 | 17.76 |
03:10 ET | 558 | 17.8 |
03:12 ET | 706 | 17.825 |
03:14 ET | 2321 | 17.9 |
03:15 ET | 4392 | 17.935 |
03:17 ET | 3187 | 18 |
03:19 ET | 500 | 17.98 |
03:21 ET | 5898 | 18 |
03:24 ET | 2300 | 18 |
03:26 ET | 600 | 17.985 |
03:28 ET | 16831 | 17.92 |
03:30 ET | 800 | 17.96 |
03:32 ET | 300 | 17.975 |
03:33 ET | 2805 | 17.99 |
03:35 ET | 1347 | 17.96 |
03:37 ET | 3271 | 17.985 |
03:39 ET | 2271 | 18.04 |
03:42 ET | 1364 | 18.015 |
03:44 ET | 1719 | 18.015 |
03:46 ET | 2169 | 18.05 |
03:48 ET | 954 | 18.02 |
03:50 ET | 1100 | 18 |
03:51 ET | 2289 | 18.02 |
03:53 ET | 7503 | 18.03 |
03:55 ET | 3957 | 17.99 |
03:57 ET | 22350 | 17.995 |
04:00 ET | 195362 | 17.96 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcus Biosciences Inc | 1.6B | -5.7x | --- |
Travere Therapeutics Inc | 1.6B | -4.1x | --- |
Nurix Therapeutics Inc | 1.6B | -7.3x | --- |
Arvinas Inc | 1.7B | -4.7x | --- |
Ardelyx Inc | 1.2B | -17.1x | --- |
Arcutis Biotherapeutics Inc | 1.5B | -7.1x | --- |
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
---|---|
Revenue (TTM) | $263.0M |
Shares Outstanding | 91.5M |
Arcus Biosciences Inc does not pay a dividend. | |
Beta | 0.85 |
EPS | $-3.15 |
Book Value | $6.12 |
P/E Ratio | -5.7x |
Price/Sales (TTM) | 6.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -120.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.